Dow (DOW) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
23 Apr, 2026Benchmarking overview and peer comparison
Benchmarked against major chemical and materials peers at both segment and corporate levels, with adjustments for recent divestitures and JV treatments.
FY25 adjusted operating EBITDA growth and margin trailed peer median, mainly due to margin compression in Industrial Intermediates & Infrastructure and Performance Materials & Coatings.
SG&A plus R&D as a percentage of sales remains best in peer group, reflecting strong cost discipline.
Cash flow conversion lagged peers due to working capital use for new asset startups and lower margins.
Over $6.5B in near-term margin and cash support measures implemented, with more than half delivered in 2025.
Segment performance and focus areas
Packaging & Specialty Plastics (P&SP) outperformed peers in most metrics, driven by a differentiated portfolio, first-quartile cost position, and feedstock flexibility.
Industrial Intermediates & Infrastructure (II&I) faced EBITDA and margin pressure from weak end markets and startup costs, but is optimizing its footprint and shifting to higher-value products.
Performance Materials & Coatings (PM&C) showed strong downstream silicones growth but margin pressure in upstream siloxanes; asset shutdowns planned to improve margins.
All segments maintain top-quartile SG&A plus R&D cost discipline.
Financial metrics and capital allocation
Operating return on invested capital (3-year average) at peer median; adjusted operating EBITDA margin below peer median.
Shareholder yield and operating return on capital for 2023-2025 annual average at or above peer median.
Continued focus on delivering cost savings, operational excellence, and portfolio optimization for growth.
Latest events from Dow
- Q2 2026 sales rose 20% to $12.1B, with strong EBITDA and margin recovery across all segments.DOW
Q2 202624 Jul 2026 - Q1 2025 net loss of $290–$307M; $6B in cash actions underway amid margin and cost headwinds.DOW
Q1 20258 Jul 2026 - Q2 2024 net sales fell 4% to $10.9B, with sequential earnings growth and strong cash returns.DOW
Q2 20248 Jul 2026 - Q3 sales and EBIT grew, but net income fell as costs rose; strategic actions support long-term growth.DOW
Q3 20248 Jul 2026 - Earnings outlook raised as tight supply and cost savings drive strong margin and EBITDA growth.DOW
16th Annual Wells Fargo Industrials & Materials Conference9 Jun 2026 - All voting items passed as leaders outlined cost savings, growth, and resilience plans.DOW
AGM 202614 May 2026 - Q1 2026 saw $9.8B sales, $873M EBITDA, a net loss, and improved cash flow from a legal settlement.DOW
Q1 202626 Apr 2026 - Proxy seeks approval for director elections, pay, plan amendment, and auditor, with ESG focus.DOW
Proxy Filing18 Mar 2026 - Record sales, tight supply, and $1B+ savings drive margin gains amid global volatility.DOW
JPMorgan Industrials Conference 202618 Mar 2026